Innovate ADHD logo
Skip to article

Medication and treatment

ADHD medication titration: the process, your observations and your questions

Starting medication, recording your experience and preparing for each review.

General information only. This article provides general information and should not be used as medical advice. It does not replace individual advice, diagnosis or treatment from a qualified healthcare professional. Speak to your clinician or pharmacist about your own health or treatment.

Clinical review pending. Source checking does not replace clinical review.

“Titration” can sound like a laboratory procedure. In ADHD care, it describes the period when a prescriber gradually adjusts medication and checks how you respond. If you are about to start, it is reasonable to want more than a prescription: you may want to know what you should notice, what to record and who to contact when something is unclear.

This guide explains the process without giving a dosing timetable. Instructions must be specific to your medicine and your circumstances. A dose used by someone else is not a target for you.1

Key points

  • Titration involves checking benefit and unwanted effects while treatment is adjusted.
  • The pace depends on the person; a fixed finish date should not be assumed.
  • Your observations and the measurements requested by your clinician are different parts of the review.1

What is the prescriber trying to find?

The prescriber may adjust treatment upwards or downwards, according to response and tolerability.1

NICE recommends slower adjustment and closer monitoring with certain other neurodevelopmental, mental health or physical conditions. Tell the prescriber about your wider health rather than assuming a previous diagnosis is unrelated.2

Before the first dose

Bring information about health changes or investigations. Ask how initial blood pressure, pulse and weight checks will be arranged.1

For methylphenidate, the NHS highlights heart problems, high blood pressure, epilepsy, tics, glaucoma, mental health conditions and problems involving drugs or alcohol as issues to raise. It also asks about pregnancy or breastfeeding. A condition on this list is a reason for assessment, not a diagnosis you should interpret as an automatic decision for or against treatment.3

Include medicines you buy yourself

Tell your prescriber or pharmacist about other medicines, herbal remedies, vitamins and supplements. With methylphenidate, some antidepressants, epilepsy medicines, blood-pressure medicines and other treatments may interact. Certain cough and cold products can also affect blood pressure. Ask before adding an over-the-counter remedy; being available without a prescription does not establish compatibility.4

Preparation prompt: bring the names or packets of what you actually take. Include occasional products, and say if you are unsure of a name. This is a suggested way of preparing for the conversation, not a complete interaction assessment.

What information is useful between appointments?

NHS inform suggests recording symptoms before and after treatment, using a diary or rating scale and noting side effects. Discuss these observations with the clinician. People close to you may notice a change that you have not recognised; whether to involve them is a personal choice.5

An optional notes format: use a few short headings rather than writing a detailed daily account:

  • What I took: the product name and the information your prescriber has asked you to record.
  • What became easier: a concrete observation from an ordinary situation.
  • What remained difficult: include times or settings where you still wanted help.
  • What concerned me: describe the experience and when it happened, without having to decide its cause.
  • My question: what you most want the next review to address.

These are optional notes for your conversation. If your clinician supplies a symptom scale or form, use the requested format. You can ask how much detail is enough, particularly if recording itself is difficult to keep up with.

Why the exact product matters

Different long-acting methylphenidate medicines release their ingredient in different patterns. Some also have different food instructions. Switching can change symptom control or unwanted effects, even though the ingredient name looks familiar. The MHRA advises caution and discussion when changing products.6

When a packet looks different, check the product and instructions with the pharmacist. If a switch has been agreed, ask what changes to watch for and whom to tell. A useful note for a later review is the date of the switch and the product name, rather than just “my tablets changed”.6

Practical arrangements are part of the conversation

Before you leave a review, ask for clarity about the next appointment, any requested measurements and the contact route for questions. Write down which instructions apply until the next review. If you cannot attend, contact the service promptly to discuss rearranging; do not assume a missed appointment has automatically been replaced. NHS service information also distinguishes routine contact from urgent help.7

Shared care means a GP and specialist service have agreed responsibilities for ongoing treatment. The CNTW NHS leaflet explains that GP agreement is a decision, not an automatic consequence of reaching a stable dose. Ask who will prescribe and monitor your medicine if a transfer is being considered.7

Questions people often ask

How long will titration take?

Ask what review intervals are planned and what would lead your prescriber to reconsider the approach. Gradual adjustment responds to the individual; another person's experience is not your timetable.1

Does a higher dose mean a better result?

The purpose is an appropriate balance of benefit and tolerability. The specialist may reconsider treatment rather than keep increasing it. NHS Specialist Pharmacy Service guidance supports individual review and alternative treatment when response is inadequate. Bring both useful changes and problems to the discussion; an increase is not a measure of progress by itself.8

What if I miss a dose?

Use the instructions for your medicine. For methylphenidate, the NHS says to skip a missed dose and not double the next one. If you are unsure whether you have taken it, or the directions do not fit your situation, ask a pharmacist or the prescribing team rather than improvising.9

Can I crush a tablet if swallowing is difficult?

Do not assume you can. The NHS specifically warns against crushing or breaking slow-release methylphenidate tablets, because this changes how they work. Instructions differ for other preparations. Tell your prescriber about swallowing difficulty and ask the pharmacist to check your exact product before altering it.9

Can a symptom diary replace blood-pressure readings?

No: the diary describes your experience, while a blood-pressure test measures something you may not feel. High blood pressure usually causes no symptoms. Ask how to obtain the readings your team requests and how to send them; a diary cannot establish that blood pressure is normal.10

When to get help before the next review

Do not wait for a routine appointment if you are worried about a possible medicine problem. Contact the prescriber or pharmacist, and use the urgent instructions in the leaflet when applicable. This is particularly important after a product change. Our monitoring and safety guide explains medicine-specific warning signs and UK urgent-care routes.6

References

  1. Northamptonshire Healthcare NHS Foundation Trust: Adult ADHD service—titration explanation.

    Back to text ↑
  2. NICE NG87: ADHD diagnosis and management.

    Back to text ↑
  3. NHS: Who can and cannot take methylphenidate for adults.

    Back to text ↑
  4. NHS: Methylphenidate with other medicines and supplements.

    Back to text ↑
  5. NHS inform: Clinical treatments for ADHD.

    Back to text ↑
  6. MHRA: Caution when switching long-acting methylphenidate products.

    Back to text ↑
  7. Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust: Adult ADHD service leaflet.

    Back to text ↑
  8. NHS Specialist Pharmacy Service: Prescribing and switching modified-release methylphenidate.

    Back to text ↑
  9. NHS: How and when to take methylphenidate for adults.

    Back to text ↑
  10. NHS: Blood pressure test.

    Back to text ↑
Disability Confident accreditation
Institute of Directors Code of Conduct accreditation
Cyber Essentials Certified
CQC accreditation

© 2026 Innovate ADHD LTD. All rights reserved.

Trading Name:
Innovate ADHD

Legal Entity:
INNOVATE ADHD LTD

Registered in:
England and Wales

Company Number:
16314966

Registered Office:
1 Mark Square, London, EC2A 4EG

Data Protection (ICO):
ZB881633

NHS Organisation Code (ODS):
N6V9E

Disability Confident Scheme:
DCS047529